Macrocyclic Plasmin Inhibitor

Macrocyclic Plasmin Inhibitor Descriptor: (5S,8R,18S,21R)-N-{[4-(aminomethyl)phenyl]methyl}-21-[(benzenesulfonyl)amino]-3,11,20-trioxo-2,5,8,12,19-pentaazatetracyclo[21.2.2.2~5,8~.2~13,16~]hentriaconta-1(25),13,15,23,26,28-hexaene-18-carboxamide, Activation peptide, GLYCEROL, ... Authors: Guojie, W. Deposit date: 2022-11-20 Release date: 2023-02-08 Last modified: 2024-11-20 Method: X-RAY DIFFRACTION (1.47 Å) Cite: Synthesis and structural characterization of new macrocyclicplasmin inhibitors Chemmedchem, 2023大环纤溶酶抑制剂描述符：(5S,8R,18S,21R)-N-{[4-(氨基甲基)苯基]甲基}-21-[(苯磺酰基)氨基]-3,11,20-三氧代-2,5,8,12,19-五氮杂四环[21.2.2.2~5,8~.2~13,16~]三十一碳-1(25),13,15,23,26,28-六烯-18-甲酰胺、激活肽、甘油等。作者：Guojie, W. 提交日期：2022-11-20，发布日期：2023-02-08，末次修改日期：2024-11-20。表征方法：X射线衍射（1.47埃）。引用文献：《新型大环纤溶酶抑制剂的合成与结构表征》，Chemmedchem，2023年